Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session 1: Lymphoma
How To Approach Patients With Untreated And Relapsed Mantle Cell
Friday, April 22, 2022
9:40 AM – 10:00 AM
Speaker(s)
Tycel Phillips, MD
Associate Professor
University of Michigan
Ann Arbor, Michigan
Learning Objectives:
Explain the mechanism of action for BTK inhibitors, including the difference between covalent and non-covalent agents
Evaluate the most recent clinical efficacy and safety data surrounding BTK inhibitors in MCL
Summarize strategies for managing toxicities and co-morbidities in MCL patients receiving BTK inhibitor therapy